{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:54:10Z","timestamp":1794473650235,"version":"4.9.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ccell.2025.02.010","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:42:39Z","timestamp":1741603359000},"page":"361-379.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Jianzhou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Fidelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Rauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Pizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sitterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Piccinno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylv\u00e8re","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Iebba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Felchle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Mallard de La Varende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius Clemens","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F.","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Demaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Formenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Belluomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Dionisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Quevrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Cl\u00e9menson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Di Cataldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Arilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Trommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Wegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Neppl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Riechelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos P.","family":"Camandaroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elson Santos","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Edouard","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Segata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Holicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Galluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitziber","family":"Buqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Alves Costa Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Derosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-0998","authenticated-orcid":false,"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.02.010_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.02.010_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ccell.2025.02.010_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.02.010_bib4","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2017.76.2229","article-title":"Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors","volume":"36","author":"Luke","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","article-title":"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial","volume":"15","author":"Kwon","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/cncr.32599","article-title":"A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer","volume":"126","author":"Ho","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2025.02.010_bib8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.eururo.2020.07.032","article-title":"Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors","volume":"78","author":"Fizazi","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2025.02.010_bib9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","article-title":"Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial","volume":"2","author":"Parikh","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2025.02.010_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2021.08.011","article-title":"Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial","volume":"81","author":"Kwan","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2025.02.010_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.eururo.2021.12.006","article-title":"Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial","volume":"81","author":"Siva","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2025.02.010_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1200\/JCO.20.00290","article-title":"Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma","volume":"39","author":"McBride","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2020.08.018","article-title":"A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma","volume":"109","author":"Mahmood","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ccell.2025.02.010_bib14","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/1078-0432.CCR-20-2474","article-title":"Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer","volume":"27","author":"Segal","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.02.010_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2021.09.016","article-title":"Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study","volume":"81","author":"Masini","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2025.02.010_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(22)01659-2","article-title":"Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial","volume":"400","author":"Kim","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2025.02.010_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(21)00658-6","article-title":"Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial","volume":"23","author":"Schoenfeld","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/noac099","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial","volume":"25","author":"Omuro","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jamaoncol.2023.2132","article-title":"Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial","volume":"9","author":"Spaas","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib20","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ccell.2025.02.010_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022\u00a0Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib24","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","article-title":"Gut microbiome correlates of response and toxicity following anti-CD19 CAR T\u00a0cell therapy","volume":"28","author":"Smith","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib26","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","article-title":"A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy","volume":"29","author":"Stein-Thoeringer","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib27","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2015-04-638858","article-title":"Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome","volume":"126","author":"Weber","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.02.010_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib32","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib33","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.02.010_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ccell.2022.11.013","article-title":"Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer","volume":"41","author":"Teng","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib35","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/2159-8290.CD-21-0236","article-title":"Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?","volume":"11","author":"Derosa","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.02.010_bib36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41591-020-0882-8","article-title":"Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer","volume":"26","author":"Roberti","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo2296","article-title":"A microbiota-modulated checkpoint directs immunosuppressive intestinal T\u00a0cells into cancers","volume":"380","author":"Fidelle","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib38","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.010_bib39","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","volume":"186","author":"Bender","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib40","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","article-title":"Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity","volume":"41","author":"Yan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib41","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","article-title":"Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring","volume":"41","author":"Colbert","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-024-01970-8","article-title":"An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer","volume":"23","author":"Levy","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.02.010_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib44","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/2159-8290.CD-21-0999","article-title":"Cancer Induces a Stress Ileopathy Depending on beta-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis","volume":"12","author":"Yonekura","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.02.010_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03235-19","article-title":"Syntrophy via\u00a0Interspecies H(2) Transfer between Christensenella and Methanobrevibacter Underlies Their Global Cooccurrence in the Human Gut","volume":"11","author":"Ruaud","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ccell.2025.02.010_bib46","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nmeth.4468","article-title":"Accessible, curated metagenomic data through ExperimentHub","volume":"14","author":"Pasolli","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.02.010_bib47","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.02.010_bib48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.annonc.2022.07.001","article-title":"Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors","volume":"33","author":"Peyraud","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib49","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","article-title":"Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials","volume":"74","author":"Dambrova","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ccell.2025.02.010_bib50","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.cell.2024.05.029","article-title":"Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome","volume":"187","author":"Derosa","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib51","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","article-title":"Environmental factors shaping the gut microbiome in a Dutch population","volume":"604","author":"Gacesa","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.02.010_bib52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T\u00a0cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib53","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10434-000-0526-7","article-title":"Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature","volume":"7","author":"Damron","year":"2000","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ccell.2025.02.010_bib54","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1038\/s41467-020-17644-0","article-title":"Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer","volume":"11","author":"Buque","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.02.010_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chom.2023.01.013","article-title":"Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance","volume":"31","author":"Zhang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ccell.2025.02.010_bib56","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/gutjnl-2017-314814","article-title":"The oral microbiota in colorectal cancer is distinctive and predictive","volume":"67","author":"Flemer","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ccell.2025.02.010_bib57","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.chom.2021.03.016","article-title":"Microbiota regulate innate immune signaling and protective immunity against cancer","volume":"29","author":"Xing","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ccell.2025.02.010_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","article-title":"Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians","volume":"599","author":"Sato","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.02.010_bib59","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1128\/AEM.65.8.3738-3741.1999","article-title":"Identification of Ruminococcus flavefaciens as the predominant cellulolytic bacterial species of the equine cecum","volume":"65","author":"Julliand","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ccell.2025.02.010_bib60","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1194\/jlr.RA120001021","article-title":"Biogeography of microbial bile acid transformations along the murine gut","volume":"61","author":"Marion","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ccell.2025.02.010_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo2003","article-title":"Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity","volume":"8","author":"Choi","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2025.02.010_bib62","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI121668","article-title":"IL-7 receptor influences anti-TNF responsiveness and T\u00a0cell gut homing in inflammatory bowel disease","volume":"129","author":"Belarif","year":"2019","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ccell.2025.02.010_bib63","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1073\/pnas.161126098","article-title":"IL-7 is critical for homeostatic proliferation and survival of naive T\u00a0cells","volume":"98","author":"Tan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.02.010_bib64","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/sj.bjc.6602518","article-title":"Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming","volume":"92","author":"Merrick","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2025.02.010_bib65","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.4049\/jimmunol.173.4.2462","article-title":"Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells","volume":"173","author":"Liao","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2025.02.010_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.02.010_bib67","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201915","article-title":"Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation","volume":"218","author":"Yang","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib68","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1172\/JCI124332","article-title":"Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response","volume":"130","author":"Uribe-Herranz","year":"2020","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ccell.2025.02.010_bib69","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1158\/2159-8290.CD-21-0900","article-title":"Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1","volume":"12","author":"Yuan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.02.010_bib70","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1158\/2159-8290.CD-22-1338","article-title":"BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance","volume":"13","author":"Zhao","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.02.010_bib71","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/microorganisms9061252","article-title":"Identifying a Novel Bile Salt Hydrolase from the Keystone Gut Bacterium Christensenella minuta","volume":"9","author":"Dejean","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ccell.2025.02.010_bib72","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib73","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s43018-021-00245-1","article-title":"Radiation-activated secretory proteins of Scgb1a1(+) club cells increase the efficacy of immune checkpoint blockade in lung cancer","volume":"2","author":"Ban","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2025.02.010_bib74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.02.010_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg0539","article-title":"PD-1 blockade increases the self-renewal of stem-like CD8 T\u00a0cells to compensate for their accelerated differentiation into effectors","volume":"8","author":"Gill","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2025.02.010_bib76","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T\u00a0cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add7446","article-title":"Rapid recruitment and IFN-I-mediated activation of monocytes dictate focal radiotherapy efficacy","volume":"8","author":"Tadepalli","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2025.02.010_bib78","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.immuni.2016.11.008","article-title":"Cholesterol Accumulation in CD11c(+) Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease","volume":"45","author":"Ito","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.02.010_bib79","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","article-title":"Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity","volume":"25","author":"Westerterp","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.ccell.2025.02.010_bib80","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.02.010_bib81","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41467-017-02186-9","article-title":"Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer","volume":"8","author":"Veglia","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.02.010_bib82","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized lipids block antigen cross-presentation by dendritic cells in cancer","volume":"192","author":"Ramakrishnan","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2025.02.010_bib83","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2012-05-431718","article-title":"IL-7 and IL-15 instruct the generation of human memory stem T\u00a0cells from naive precursors","volume":"121","author":"Cieri","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.02.010_bib84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2019.01.006","article-title":"Clonal Deletion of Tumor-Specific T Cells by Interferon-gamma Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade","volume":"50","author":"Pai","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.02.010_bib85","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1172\/JCI127458","article-title":"Type I IFN protects cancer cells from CD8+ T\u00a0cell-mediated cytotoxicity after radiation","volume":"129","author":"Chen","year":"2019","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ccell.2025.02.010_bib86","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib87","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccell.2022.12.008","article-title":"Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.02.010_bib88","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1158\/1078-0432.CCR-20-4521","article-title":"Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy","volume":"27","author":"Chen","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.02.010_bib89","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1078-0432.CCR-19-3624","article-title":"Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma","volume":"26","author":"Xie","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.02.010_bib90","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.mcb.2021.04.001","article-title":"The intracellular metabolome of starving cells","volume":"164","author":"Durand","year":"2021","journal-title":"Methods Cell Biol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:50:52Z","timestamp":1741603852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1535610825000625"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.02.010","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}